Agios Pharmaceuticals
AGIO
AGIO
185 hedge funds and large institutions have $1.81B invested in Agios Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 62 increasing their positions, 57 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
9% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 57
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
20% less call options, than puts
Call options by funds: $12.5M | Put options by funds: $15.5M
Holders
185
Holding in Top 10
2
Calls
$12.5M
Puts
$15.5M
Top Buyers
| 1 | +$41.6M | |
| 2 | +$19M | |
| 3 | +$15M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$11.8M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$11.7M |
Top Sellers
| 1 | -$40.5M | |
| 2 | -$23.7M | |
| 3 | -$16.4M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$11.3M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$8.9M |